CCR Connections

Skip to Main Content

Ronald E. Gress, M.D.
Ronald Gress has been named a Deputy Director of CCR. He received his M.D. from Baylor College of Medicine and completed his residency and clinical oncology training at The Johns Hopkins Hospital and further fellowship training in oncology and basic immunology at the NCI. In 2000, he became Chief of CCR’s Experimental Transplantation and Immunology Branch and has established a highly successful bone marrow transplant program with an active clinical component and state-of-the-art bone marrow transplantation unit in the NIH Clinical Center. His research focuses on transplantation immunology with emphasis on the regulation of allogeneic responses and the mechanisms by which peripheral lymphocyte populations are generated and maintained. As a Deputy Director, he will help guide the CCR clinical program.

Federico Bernal, Ph.D.
Federico Bernal joins CCR’s Metabolism Branch. He received his Ph.D. from The Scripps Research Institute after performing work on the development of synthetic methodologies for the construction of complex marine natural products in the laboratory of Dr. K.C. Nicolaou. He completed his postdoctoral training in chemical biology under the supervision of Dr. Gregory Verdine at Harvard University followed by additional studies in the same area in the laboratory of Dr. Loren Walensky at the Dana-Farber Cancer Institute. His research investigates the use of synthetic molecules to manipulate cancer pathogenesis pathways.

Terry Fry, M.D.
Terry Fry rejoins CCR’s Pediatric Oncology Branch after serving as Chief of the Division of Blood and Marrow Transplantation at Children’s National Medical Center since 2007. Dr. Fry obtained his M.D. from Georgetown University. After completing a pediatric residency at Georgetown, he received fellowship training in pediatric hematology and oncology at The Johns Hopkins University and worked in the CCR laboratory of Dr. Crystal Mackall as part of that training. He continued working in Dr. Mackall’s laboratory as a Postdoctoral Fellow and was a Staff Clinician in the Pediatric Oncology Branch from 2004 until 2007, when he left for Children’s National Medical Center in Washington, DC.

James Gulley, M.D., Ph.D.
James Gulley has been promoted to tenure-track scientist in CCR’s Laboratory of Tumor Immunology and Biology, where he serves as the Director of the Clinical Trials Group. He is also a Principal Investigator in the Medical Oncology Branch. He received his medical training at Loma Linda University in its medical scientist training program where he obtained an M.D. and Ph.D. for his work in tumor immunology. He completed his residency in internal medicine at Emory University and then came to NCI for a fellowship in medical oncology. Following his fellowship, he was retained as a staff clinician at NCI. Since 1999, Dr. Gulley has run multiple clinical trials in immunotherapy for prostate cancer. He has received numerous awards and has authored over 130 original articles, reviews, and book chapters on immunotherapy and cancer treatments. His research focuses on the use of cancer vaccines and other immunostimulatory molecules to modulate the immune response in cancer patients and to enhance vaccine-mediated killing.